GTCM
VIR icon

Gyon Technologies Capital Management’s Vir Biotechnology VIR Stock Holding History

Gyon Technologies Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,644
Closed -$269K – 408
2022
Q4 		$269K Buy
+10,644
New +$261K 0.1% 196

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Gyon Technologies Capital Management's VIR Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of Vir Biotechnology (VIR) in Q1 2023, closing a stake of 10,644 shares — an estimated $269K sold.

Gyon Technologies Capital Management first reported a position in VIR in Q4 2022 and held it in 1 quarter. The position peaked at $269K in Q4 2022. 231 funds tracked by Wall St. Rank hold VIR as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining Vir Biotechnology position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 10,644 Vir Biotechnology shares in Q1 2023, an estimated $269K.
  • Gyon Technologies Capital Management first reported a position in Vir Biotechnology in Q4 2022 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Vir Biotechnology position peaked at $269K in Q4 2022.
  • 231 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.